Home > Insider Trading > Filing (0000899243-20-017609)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1538927	Forma Therapeutics Holdings Inc.	FMTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1298814	Marsha Fanucci	C/O Forma Therapeutics Holdings, Inc. 500 Arsenal Street, Suite 100 Watertown MA 02472		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-23	52,532	$0.00	52,532	No	4	P	Direct
Enterprise 2 Junior Stock	Disposition	2020-06-23	33,781	$0.00	0	No	4	S	Direct
Enterprise 3 Junior Stock	Disposition	2020-06-23	9,847	$0.00	0	No	4	S	Direct
Enterprise 4 Junior Stock	Disposition	2020-06-23	10,240	$0.00	0	No	4	S	Direct
Enterprise 5 Junior Stock	Disposition	2020-06-23	14,026	$0.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Effective immediately upon the closing of the Registrant's initial public offering on June 23, 2020, the reporting person converted (i) 33,781 shares of Enterprise 2 Junior Stock at a conversion rate of 0.8179 shares of common stock per one share of Enterprise 2 Junior Stock, (ii) 9,847 shares of Enterprise 3 Junior Stock at a conversion rate of 0.7822 shares of common stock per one share of Enterprise 3 Junior Stock, (iii) 10,240 shares of Enterprise 4 Junior Stock at a conversion rate of 0.7585 shares of common stock per one share of Enterprise 4 Junior Stock, and (iv) 14,026 shares of Enterprise 5 Junior Stock at a conversion rate of 0.6727 shares of common stock per one share of Enterprise 5 Junior Stock, resulting in her acquisition of 52,532 shares of common stock.